Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00685295 · ClinicalTrials.gov registry record · Phase 1
Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain
A Phase 1 study of Pain, Fracture, Sprain, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT00685295: Completed Phase 1 study of Pain, Fracture, Sprain, sponsored by Massachusetts General Hospital.
NCT00685295 is a Phase 1 study of Pain, Fracture, Sprain that has completed, run by Massachusetts General Hospital. The registered enrollment target is 60 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00685295, a Phase 1 study of Pain, Fracture, Sprain, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Assess whether transbuccal fentanyl provides more rapid relief of orthopedic pain, than does the comparator Percocet
Primary Outcome
Time it took for subjects to achieve a pain score reduction of 2 units (on a 0 to 10 scale)
Conditions Studied
Interventions
- DRUG Oxycodone
- DRUG Fentanyl
- DRUG Lansoprazole
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-02 |
| Phase | Phase 1 |
What the finished NCT00685295 record still lists
NCT00685295 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.
The record links to 1 condition, with Pain, Fracture, Sprain appearing as the primary indexed condition, and to 3 interventions - of which Oxycodone is the first listed.
NCT00685295 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00685295 about?
NCT00685295 is a clinical study titled "Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain". Assess whether transbuccal fentanyl provides more rapid relief of orthopedic pain, than does the comparator Percocet
What is the current status of trial NCT00685295?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2008-08. Estimated completion is 2009-02.
What conditions does trial NCT00685295 study?
This clinical trial studies the following conditions: Pain, Fracture, Sprain.
What interventions are being tested in trial NCT00685295?
The interventions under investigation include: Oxycodone (DRUG), Fentanyl (DRUG), Lansoprazole (DRUG).
Who is sponsoring clinical trial NCT00685295?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00685295 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00685295's enrollment target sits among peer trials
60 831st of 2000 higher than 1,106 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia